The Safety and Efficacy of an Oral Superfruits Supplement
1 other identifier
interventional
15
1 country
1
Brief Summary
This study is conducted to evaluate the safety and effectiveness of an oral superfruits supplement for skin brightening and wrinkle reduction. Superfruits are reported to have high bioactive compounds with beneficial effects on human health. The study duration is 12 weeks and the skin assessment will be carried out at baseline, week 2, week 6 and week 12. The participants will consume the supplement for 6 weeks and at week 12, final skin assessment will be conducted. The main questions this study aims to answer are:
- 1.The skin brightening effect of the oral superfruits supplement.
- 2.The effect of the oral superfruits supplement on wrinkle reduction.
- 3.To observe any adverse effect occurrence with the consumption of the oral superfruits supplement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Dec 2022
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 11, 2023
CompletedFirst Posted
Study publicly available on registry
January 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedMarch 28, 2025
March 1, 2025
7 months
January 11, 2023
March 24, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Changes in skin tone from baseline and at week 2, week 6 and week 12 after consumption of the superfruits supplement
Skin tone will be assessed using JANUS III skin analyzer
Baseline, week 2, week 6 and week 12
Changes in skin wrinkles from baseline and at week 2, week 6 and week 12 after consumption of the superfruits supplement
Skin wrinkles will be assessed using JANUS III skin analyzer and Wrinkle Severity Rating Scale (WSRS). For WSRS, dermatologists will evaluate participants' wrinkles based on 5-point photonumeric rating scale that will objectively evaluate the severity of crow's feet at rest (static) and with a smiling expression (dynamic). The scale scores are 0 for no wrinkles, 1 for very fine wrinkles, 2 for fine wrinkles, 3 for moderate wrinkles, and 4 for severe wrinkles.
Baseline, week 2, week 6 and week 12
Adverse effect after consumption of the superfruits supplement
Based on adverse effect occurrence on participants that occur during study period (12 weeks)
Week 12
Study Arms (1)
Oral superfruits supplement
EXPERIMENTALParticipants will consume oral superfruits supplement once daily for 6 weeks.
Interventions
The supplement contain superfruits that are beneficial for human health
Eligibility Criteria
You may qualify if:
- Malaysian citizen
- Male and female (age 20-60 years old)
You may not qualify if:
- Participant who taking any dietary supplements for the past 4 weeks which can affect the study results
- Participant who are on contraceptive pills for the past 3 months
- Participant who undergo cosmetics treatments such as botox, filler and laser and light treatment within the last 3 months
- Pregnant or plans to get pregnant and breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
Petaling Jaya, Selangor, 47810, Malaysia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2023
First Posted
January 23, 2023
Study Start
December 1, 2022
Primary Completion
June 30, 2023
Study Completion
December 1, 2023
Last Updated
March 28, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share